nSpire Health has entered into a three-year contract with Amerinet Group Purchasing Organization. The agreement offers Amerinet customer hospitals and clinics exclusive access to nSpire Health’s broad range of respiratory products and services, including the newly released HDpft pulmonary function testing systems through June 30, 2013.
Amerinet said that its customers will be able to take advantage of several new advancements in lung function diagnostics, including iFlow, nSpire Health’s newest development in flow sensor technology with the added benefits of HDpft .
nSpire Health and Amerinet said that the iFlow ensures flow and volume measuring accuracy and reproducibility at more than three times the industry standard, while nSight software streamlines testing, delivering the industry’s fastest start-to-finish exam times.
Consistent with nSpire Health’s vision of revolutionising the way the world detects and treats respiratory diseases, HDpft technology identifies smaller changes in lung function sooner.
Rich Rosenthal, VP of sales and marketing at nSpire Health, said: “nSpire Health is pleased to support the Amerinet membership with advanced and emerging technologies. I am confident that our agreement, coupled with nSpire Health’s emphasis and commitment to customer satisfaction, will facilitate Amerinet’s on-going mission to improve healthcare quality.”